Biosimilars Review & Report's Stan Mehr, Samsung Bioepis' Sang-Jin Pak, Sandoz's Carol Lynch and Mylan's Chrys Kokino talk interchangeability at the AAM meeting. • Source: Sue Sutter
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
